Liverpool Course 2022
Related Enduring Materials
Program
Welcome
Designed and developed by renowned experts in the field of HIV care and pharmacology, the Liverpool Course aims to educate participants on key concepts in clinical pharmacology and drug-drug interactions that remain a major consideration in the management of people living with HIV.
The course is organized in collaboration with the University of Liverpool and the leading experts who developed the Liverpool HIV drug interactions checker - a comprehensive drug-drug-interaction resource freely available to healthcare practitioners worldwide.
General Information
We are available to answer any questions or concerns that you may have about your participation in the Liverpool Course 2022. For more information, please contact Brenda Evan at Brenda.Evan@amededu.com
- Secondary: ID physicians, pharmacists, specialist nurses.
- Tertiary: Researchers.
- Reinforce and develop the understanding of key clinical pharmacology concepts among junior colleagues in the fields of infectious diseases and hepatology (clinicians, pharmacists, academics, industry colleagues etc.).
- Improve clinical pharmacology education and thereby the quality of patient care.
- Educate healthcare professionals on how to use the Liverpool Drug Interaction Resources in their clinical practice.
- Increase knowledge and confidence among healthcare professionals through practical examples of the Liverpool Drug Interactions Resources and discussion of case studies tailored to the local needs.
- Describe in detail the terms pharmacodynamics and pharmacokinetics.
- Define what is meant by clinically significant DDI and discuss DDI mechanisms.
- Use the Liverpool DDI Resource with confidence in their daily practice.
- Identify the potential of DDIs of ARVs and DAAs and use this information to improve their decision making in daily practice.
Practical Information
Become an Endorser
If you would like your organization to support the Liverpool Course as an endorser or media partner, please contact Brenda Evan at Brenda.Evan@amededu.com.
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals and researchers interested in key concepts in clinical pharmacology and drug-drug interactions.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause, get in touch with us for a tailored
support package by contacting Rikke Puggaard-Rode at Rikke.Rode@amededu.com or call +31 30 230 7147.
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
- Non-commercial interviews with company representatives
- Verbal acknowledgement during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Company acknowledgement on printed meeting materials including but not limited to banners and the program book
- Digital and printed advertising opportunities
- Social media shout-outs
- Logo on the conference bag
*Subject to the support level.
Accreditation Statement
The Liverpool Course 2022, Utrecht (livestream), Netherlands, 28/09/2022-28/09/2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 2 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Previous Editions
- 3rd Edition - Liverpool Course, 2021, Virtual (https://academicmedicaleducation.com/liverpool-course-2021)
- 2nd Edition - Liverpool Course, 2020, Virtual (https://academicmedicaleducation.com/liverpool-course-2020)
- 1st Edition - Liverpool Course 2019, Lithuania (https://academicmedicaleducation.com/meeting/liverpool-course-2019)
Top-Rated Materials from Previous Editions
Clinical Pharmacology of Long-Acting Therapy - Marta Boffito, MD, PhD, FRCP
Liverpool Course 2021
